Tomohiro Shibata

Matsumoto, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells.

EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells.

Journal: PloS one
Published: August 03, 2025

Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells.

Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells.

Journal: Cancer science
Published: December 19, 2021

The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time.

The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time.

Journal: Journal of cancer research and clinical oncology
Published: May 27, 2021

Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.

Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.

Journal: PloS one
Published: February 01, 2021

Selective Covalent Targeting of Mutated EGFR(T790M) with Chlorofluoroacetamide-Pyrimidines.

Selective Covalent Targeting of Mutated EGFR(T790M) with Chlorofluoroacetamide-Pyrimidines.

Journal: ACS medicinal chemistry letters
Published: December 04, 2019

Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance.

Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance.

Journal: Molecular cancer therapeutics
Published: July 12, 2019

NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells.

NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells.

Journal: Communications biology
Published: March 18, 2019

Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.

Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.

Journal: Cancer research
Published: February 05, 2019

Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer.

Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer.

Journal: Cancer science
Published: January 21, 2019

Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer.

Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer.

Journal: Oncotarget
Published: November 08, 2018

Selective and reversible modification of kinase cysteines with chlorofluoroacetamides.

Selective and reversible modification of kinase cysteines with chlorofluoroacetamides.

Journal: Nature chemical biology
Published: August 15, 2017

Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression.

Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression.

Journal: Cancer research
Published: June 07, 2016
Showing 1-12 of 18

Last Updated: 09/26/2026